Description
A DHCR7 inhibitor that prevents cholesterol biosynthesis and Hedgehog signaling; used to recapitulate phenotypes of Smith-Lemli-Opitz syndrome, a disorder brought about by mutations in the DHCR7 gene, in animal models
Formal name: trans-N1,N4-bis[(2-chlorophenyl)methyl]-1,4-cyclohexanedimethanamine, dihydrochloride
Synonyms:
Molecular weight: 464.3
CAS: 366-93-8
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Small Molecule Inhibitors|Sterol Biosynthesis||Research Area|Cell Biology|Cell Signaling|Hedgehog Signaling